[go: up one dir, main page]

PL3716967T3 - Kompozycje do zapobiegania lub leczenia ostrej choroby popromiennej - Google Patents

Kompozycje do zapobiegania lub leczenia ostrej choroby popromiennej

Info

Publication number
PL3716967T3
PL3716967T3 PL18882935.2T PL18882935T PL3716967T3 PL 3716967 T3 PL3716967 T3 PL 3716967T3 PL 18882935 T PL18882935 T PL 18882935T PL 3716967 T3 PL3716967 T3 PL 3716967T3
Authority
PL
Poland
Prior art keywords
prevention
compositions
treatment
acute radiation
radiation syndrome
Prior art date
Application number
PL18882935.2T
Other languages
English (en)
Inventor
Ki Young SOHN
Sun Young Yoon
Original Assignee
Enzychem Lifesciences Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020170162404A external-priority patent/KR20190063536A/ko
Application filed by Enzychem Lifesciences Corporation filed Critical Enzychem Lifesciences Corporation
Publication of PL3716967T3 publication Critical patent/PL3716967T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/193Colony stimulating factors [CSF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/18Lipids
    • A23V2250/182Diglycerides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL18882935.2T 2017-11-30 2018-11-30 Kompozycje do zapobiegania lub leczenia ostrej choroby popromiennej PL3716967T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020170162404A KR20190063536A (ko) 2017-11-30 2017-11-30 1-팔미토일-2-리놀레오일-3-아세틸글리세롤을 포함하는 급성 방사선 증후군의 예방 또는 치료용 조성물
US201862691604P 2018-06-28 2018-06-28
PCT/IB2018/059538 WO2019106632A1 (en) 2017-11-30 2018-11-30 Compositions for prevention or treatment of acute radiation syndrome

Publications (1)

Publication Number Publication Date
PL3716967T3 true PL3716967T3 (pl) 2023-12-11

Family

ID=66664840

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18882935.2T PL3716967T3 (pl) 2017-11-30 2018-11-30 Kompozycje do zapobiegania lub leczenia ostrej choroby popromiennej

Country Status (5)

Country Link
US (2) US12076307B2 (pl)
JP (1) JP2024037922A (pl)
IL (1) IL274974B2 (pl)
PL (1) PL3716967T3 (pl)
WO (1) WO2019106632A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3716967T3 (pl) 2017-11-30 2023-12-11 Enzychem Lifesciences Corporation Kompozycje do zapobiegania lub leczenia ostrej choroby popromiennej
US20220339135A1 (en) * 2019-01-07 2022-10-27 Enzychem Lifesciences Corporation Compositions and methods for modulating an inflammatory response
EP4214196A4 (en) * 2020-09-17 2025-02-19 Enzychem Lifesciences Corporation GLYCERIN COMPOUNDS AND METHODS OF USE

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050118057A (ko) 2004-04-24 2005-12-15 김상희 아세틸디아실글리세롤류의 화합물을 유효성분으로함유하는 항암제 및 건강식품
KR101278874B1 (ko) 2011-09-23 2013-06-26 주식회사 엔지켐생명과학 1-팔미토일-3-아세틸글리세롤의 제조방법 및 이를 이용한 1-팔미토일-2-리놀레오일-3-아세틸글리세롤의 제조방법
WO2015026124A1 (ko) 2013-08-19 2015-02-26 주식회사 엔지켐생명과학 모노아세틸디아실글리세롤 화합물을 유효성분으로 함유하는 천식의 예방 또는 치료용 조성물
RU2646823C2 (ru) 2013-08-19 2018-03-07 Энзикем Лайфсайенсиз Корпорейшн Композиция для предотвращения или лечения ревматоидного артрита, содержащая в качестве активного ингредиента моноацетилдиглицерид
KR20180015297A (ko) * 2014-05-15 2018-02-12 주식회사 엔지켐생명과학 백혈구 감소증 및 혈소판 감소증에 대한 치료 방법
TW201618767A (zh) * 2014-08-01 2016-06-01 安塞全生命科學公司 治療不寧腿症候群及腿痙攣的組成物及方法
US10183056B2 (en) 2014-10-16 2019-01-22 Cleveland Biolabs, Inc. Methods and compositions for the treatment of radiation-related disorders
US9808438B2 (en) * 2015-11-09 2017-11-07 Enzychem Lifesciences Corporation Method for treating mucositis
PL3716967T3 (pl) 2017-11-30 2023-12-11 Enzychem Lifesciences Corporation Kompozycje do zapobiegania lub leczenia ostrej choroby popromiennej

Also Published As

Publication number Publication date
IL274974B1 (en) 2024-11-01
IL274974B2 (en) 2025-03-01
WO2019106632A1 (en) 2019-06-06
IL274974A (en) 2020-07-30
US20200397737A1 (en) 2020-12-24
US11590096B2 (en) 2023-02-28
US12076307B2 (en) 2024-09-03
RU2020121489A (ru) 2021-12-30
JP2024037922A (ja) 2024-03-19
US20210100767A1 (en) 2021-04-08

Similar Documents

Publication Publication Date Title
IL263697A (en) Compounds, preparations and methods for the treatment and/or prevention of cancer
IL259856A (en) A preparation for the treatment of Crigler-Najjar syndrome
GB201611712D0 (en) Methods and compounds for the treatment or prevention of severe or persistent influenza
IL263793A (en) Compounds and preparations for the treatment of cancer
IL275573A (en) Methods and preparations for the treatment of hypercytokinemia and severe influenza or for their prevention
LT3573620T (lt) Kompozicijos, skirtos hipertenzijos gydymui
IL251108A0 (en) Preparations and methods for the treatment of acute radiation syndrome
IL249640A0 (en) Preparations for the treatment of nosebleeds
ZA201702639B (en) Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
IL275525A (en) A pharmaceutical preparation for the treatment of cancer
IL274974A (en) Preparations for the prevention or treatment of acute radiation syndrome
HUE065955T2 (hu) Készítmények vulvodynia kezelésére
ZA201806807B (en) Method for the treatment or prevention of osteoarthritis
EP3108884A4 (en) Composition for prevention or treatment of treatment-resistant cancer
EP3349719A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF RADIATION DERMATITIS
EP3277269A4 (en) Methods for prevention and treatment of cardiometabolic syndrome and compositions used therein
EP3716967C0 (en) COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF ACUTE RADIATION SYNDROME
PL3165229T3 (pl) Kompozycja do zapobiegania lub leczenia zespołu policystycznych jajników i związanych z nim objawów
PL3236961T3 (pl) Kompozycja farmaceutyczna do zapobiegania lub leczenia nowotworu złośliwego
IL264467B (en) Compounds and methods for the treatment of irritable bowel syndrome
SG11202000724XA (en) Methods and compositions for the treatment of cancer
IL271564A (en) Preparations for the prevention and treatment of severe kidney damage
IL267059A (en) A preparation for the treatment of osteoarthritis
IL263336B (en) Compounds for the treatment of symphysiolysis
SG11201913808SA (en) Pharmaceutical composition for preventing or treating osteoarthritis